[1] Tenofovir disoproxil fumarate (Viread, Gilead Sciences, Inc.) is a new addition to the antiretroviral armamentarium. It is an ester-derived prodrug that is converted in vivo by serum and ...

Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online Oct. 14 ...

Tenofovir disoproxil fumarate gets converted to tenofovir via hydrolyis, and subsequently phosphorylated to form tenofovir diphosphate, which inhibits reverse transcriptase by competing with the ...

Gilead is looking towards approval of lenacapavir as HIV PrEP after reporting near-perfect efficacy in the PURPOSE-1 and ...

In contrast to currently available daily HIV medications, such as Gilead’s Biktarvy (bictegravir 50mg/emtricitabine ...

High rates of virologic suppression were observed among Black patients who received long-term ART with BIC/FTC/TAF for HIV management.

Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) is a brand-name drug prescribed for HIV-1 in adults and some children. Biktarvy comes as a tablet that’s ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) is a prescription drug that’s used to treat HIV. This drug can interact with other medications and some ...

Cisgender gay and bisexual men, transgender women, and transgender men remain at higher risk for HIV acquisition.

In this randomized controlled trial, among adolescent girls and young women, it was found that twice-yearly lenacapavir ...

Generic tenofovir disoproxil fumarate/emtricitabine the most frequently prescribed medication since 2021. (HealthDay News) — Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, ...